All entries for: Ultragenyx Pharmaceutical Inc.

February 18, 2026

Ultragenyx Pharmaceutical Inc.

Neutral Outlook

Novato, CA
1,001-5,000 employees

…the IRA’s impact on competition and commercialization remains largely uncertain.

Disease Area: Multiple, Neurological Diseases, Rare Disease
Drug Type: Biologic, Small Molecule
November 5, 2025

Ultragenyx Pharmaceutical Inc.

Neutral Outlook

Novato, CA
1,001-5,000 employees

In addition, in May 2025, the Trump Administration renewed the idea of international reference pricing through an executive order entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients”, which, among other things, directs the HHS and other agencies to communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for U.S. patients in line with comparably developed nations and to facilitate direct-to-consumer purchasing programs.

Scroll to Top